medigraphic.com

2012, Number 5

<< Back

Rev Med Inst Mex Seguro Soc 2012; 50 (5)

Clinical guideline. Preeclampsia-eclampsia

Romero-Arauz JF, Morales-Borrego E, García-Espinosa M, Peralta-Pedrero ML

Language: Spanish
References: 43
Page: 569-579
PDF size: 66.33 Kb.


ABSTRACT

Preeclampsia remains a major cause of worldwide pregnancy related maternal and neonatal mortality and morbidity, it accounts for more than 50,000 maternal deaths each year. The World Health Organization estimates that at least one woman dies every 7 minutes from a complication of preeclampsia. It is the main cause of maternal death in Mexico and Latin America. Standarized assessment and surveillance of women with preeclampsia is associated with reduced maternal risk. Standarized sequence was established to search for practice guidelines from the clinical questions raised on diagnosis and treatment of preeclampsia- eclampsia. The working group selected clinical practice guidelines found in the Cochrane Library, Medline y PubMed. The results were expressed as levels of evidences and grade of recommendation. Evidence suggests, that treatment of severe hypertension, seizures prophylaxis with magnesium sulfate, and management by experienced health-care professionals will improve maternal, fetal and neonatal outcomes. Treatment remains supportive with pregnancy termination being the only definitive cure.


REFERENCES

  1. Gleicher N. Why much of the pathophysiology of preeclampsia-eclampsia must be of an autoimmune nature. Am J Obstet Gynecol 2007;196(1):5.e1-5.e7.

  2. von Dadelszen P, Magee L. What matters in preeclampsia are the associated adverse outcomes: the view from Canada. Curr Opin Obstet Gynecol 2008;20(2):110-115.

  3. Moodley J. Hypertensive emergencies in pregnancies in underresourced countries. Curr Opin Obstet Gynecol 2008;20(2):91-95.

  4. Roberts JM, Redman CW. Preeclampsia: more than pregnancy induced hypertension. Lancet 1993;341(8858):1447-1451.

  5. Steegers EA, von Dadelszen P, Duvekot JJ, Pijnenborg R. Preeclampsia: Lancet 2010;376(9741):631-644. Epub 2010 Jul 2.

  6. Roberts J, Gammill H. Preeclampsia recent insights. Hypertension, 2005;46(6):1243-9. Epub 2005 Oct 17.

  7. Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet 2005;365(9461):785-798.

  8. Duley L, Meher S, Abalos E. Management of pre-eclampsia. BMJ 2006;332(539):463-468.

  9. Norwitz E, Dong C, Reptke J. Acute complications of preeclampsia. Clin Obstet Gynecol 2002;45(2):308-329.

  10. Guía de práctica clínica: atención integral de preeclampsia en el segundo y tercer niveles de atención. México: Secretaría de Salud; 2008. Disponible en http://cvsp.cucs.udg.mx/guias/ATENCION_DE_LA_MUJER/SS_020_08_PRECLAMPSIA/SS-020-08_EyR.pdf

  11. Menzies J, Magee LA, Li J, MacNab YC, Yin R, Stuart H, et al. Instituting surveillance guidelines and adverse outcomes in preeclampsia. Obstet Gynecol 2007;110(1):121-127.

  12. Sánchez-Rodríguez EN, Nava-Salazar S, Morán-Villota C, Romero-Arauz JF, Cerbón-Cervantes MA. Estado actual de la preeclampsia en México: de lo epidemiológico a sus mecanismos moleculares. Rev Invest Clin 2010;62 (3):252-260.

  13. ACOG Committee on Obstetric Practice. Diagnosis and management of preeclampsia and eclampsia. ACOG Practice Bulletin No 33. American College of Obstetricians and Gynecologists. Obstet Gynecol 2002;99:159-167.

  14. Magee LA, Helewa M, Moutquin JM, von Dadelszen P; Hypertension Guideline Committee; Strategic Training Initiative in Research in the Reproductive Health Sciences (STIRRHS) Scholars. Diagnosis, evaluation and management of the hypertensive disorders of pregnancy. The Society of Obstetricians and Gynaecologists of Canada. J Obstet Gynaecol Can 2008;30(3 Suppl):S1-S48.

  15. Royal College of Obstetricians and Gynaecologists. Severe pre-eclampsia/eclampsia, management–Green–Top Guideline 10(A). London RCOG; 2006.

  16. Barton JR, Sibai BM. Prediction and prevention of recurrent preeclampsia. Obstet Gynecol 2008;112 (2 Pt 1):359-372.

  17. National Institute for Health and Clinical Excellence. Hypertension in Pregnancy: The Management of Hypertensive Disorders During Pregnancy. NICE Clinical Guideline 107. London, UK: National Institute for Health and Clinical Excellence; 2010. Disponible en http://www.nice.org.uk/nicemedia/ live/13098/50418/50418.pdf

  18. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol, 2000;183(1):S1-S22.

  19. Barton JR, Witlin AG, Sibai BM. Management of mild preeclampsia. Clin Obstet Gynecol 1999;42(3):455-469.

  20. Sibai BM. Diagnosis and management of gestational hypertension and preeclampsia. Obstet Gynecol 2003; 102(1):181-192.

  21. Secretaría de Salud. Lineamiento Técnico. Prevención, Diagnóstico y Manejo de la Preeclampsia/eclampsia. México: Secretaría de Salud; 2007. Disponible en http://www.salud.gob.mx/unidades/cdi/documentos/PREECLAMPSIA_ECLAMPSIA_lin-2007.pdf

  22. Sibai BM. Magnesium sulfate prophylaxis in preeclampsia: Lessons learned from recent trials. Am J Obstet Gynecol 2004;190(6):1520-1526.

  23. Mabie WC. Management of acute severe hypertension and encephalopathy. Clin Obstet Gynecol 1999;42(3):519-531.

  24. Magee LA, Cham C, Waterman EJ, Ohlsson A, von Dadelszen P. Hidralazine for treatment of severe hypertension in pregnancy: Meta-analysis. BMJ 2003;273(7421):955-960.

  25. Sibai BM, Barton JR. Expectant management of severe preeclampsia remote from term: patient selection, management, and delivery indications. Am J Obstet Gynecol 2007;196(6):514.e1-514.e9.

  26. Sambrook AM, Small RC. The treatment of hypertension in pregnancy. Anaesth Intensive Care Med 2008;9(3):128-131.

  27. Colegio Mexicano de Especialistas en Ginecología y Obstetricia. Guía de Práctica Clínica. Diagnóstico y tratamiento de la preeclampsia-eclampsia. Ginecol Obstet Mex 2010;78(6):S461-S525.

  28. Witlin AG, Sibai BM, Randomized trials for prevention and treatment of eclamptic convulsions. En: Sibai BM, editor. Hypertensive disorders in women. Philadelphia: Saunders; 2001. p. 221-227.

  29. Fonseca JE, Méndez F, Cataño C. Dexamethasone treatment does not improve the outcome of women with HELLP Syndrome: a double blind placebo controlled, randomized clinical trial. Am J Obstet Gynecol 2005;193(5):1591-1598.

  30. Martin JN Jr, Rose CH, Briery CM. Understanding and managing HELLP syndrome: the integral role of aggressive glucocorticoids for mother and child. Am J Obstet Gynecol 2006;195(4):914-934. Epub 2006 May 2.

  31. Odendaal HJ, Pattinson RC, Bam R, Grove D, Kotze TJ. Aggressive or expectant management for patients with severe preeclampsia beetween 28-34 weeks of gestation: a randomized controlled trial. Obstet Gynecol 1990;76(6): 1070-1075.

  32. Sibai BM, Mercer BM, Schiff E, Friedman SA. Aggressive versus expectant management of severe preeclampsia at 28-32 weeks of gestation: a randomized controlled trial. Am J Obstet Gynecol 1994;171(3):818-822.

  33. Amorim MM, Santos LC, Faundes A. Corticosteroid therapy for prevention of respiratory distress syndrome in severe preeclampsia. Am J Obstet Gynecol 1999;180(5):1283-1288.

  34. Romero-Arauz JF, Lara-González AL, Izquierdo-Puente JC. Manejo conservador en preeclampsia severa. Ginecol Obstet Mex 2000;68(2):51-54.

  35. Maulik D. Management of fetal growth restriction: an evidence based approach. Clin Obstet Gynecol 2006;49(2):320-334.

  36. Baschat A, Hecher K. Fetal growth restriction due to placental disease. Semin Perinatol 2004;28(1):67-80.

  37. Romero-Arauz JF, Lara-González AL, Ramos-León JC, Izquierdo-Puente JC. Utilidad de la prueba sin estrés en la preeclampsia. Ginecol Obstet Mex 2001;69(6):213-217.

  38. Romero-Arauz JF, Ramos-León JC, Rivera-Velásquez P, Álvarez-Jiménez G, Molina-Pérez CJ. Velocimetría Doppler de la arteria umbilical y resultado perinatal adverso en preeclampsia severa. Ginecol Obstet Mex 2008;76(8):440-449.

  39. Alfirevic Z, Neilson JP. Doppler ultrasonography in high risk pregnancies: systematic review with meta-analysis. Am J Obstet Gynecol 1995;172(5):1379-1387.

  40. Sibai BM, Stella CL. Diagnosis and management of atypical preeclampsia-eclampsia. Am j Obstet Gynecol 2009;200 (5):481.e1-481.e7.

  41. Airoldi J, Weinstein L. Clinical significance of proteinuria in pregnancy. Obstet Gynecol Surv 2007;62(2):117-124.

  42. Schiettcatte J, Russcher H, Anckaert E. Multicenter evaluation of the first automated Elecsys sFlt-1 and PIGF assays in normal pregnancies and preeclampsia. Clin Biochem 2010; 43(9):768-770.

  43. Sunderji S, Gaziano E, Wothe D, Sibai B. Automated assays for SVEGF and PIGF as an aid in the diagnosis of preterm preeclampsia: a prospective clinical study. Am J Obstet Gynecol 2010;202(1):40.e1-40.e7.




2020     |     www.medigraphic.com